| Period Ending | Mar 30, 2012 | Mar 30, 2011 | Mar 30, 2010 |
|---|
|
Total Revenue
|
7,301,000
|
6,964,000
|
6,058,000
| | Cost of Revenue | 5,166,000 | 4,772,000 | 4,150,000 | | |
Gross Profit
|
2,136,000
|
2,192,000
|
1,908,000
| |
|
Operating Expenses |
|
Research Development |
-
|
-
|
-
|
|
Selling General and Administrative | 943,000 | 908,000 | 745,000 |
|
Non Recurring |
-
|
-
|
-
|
|
Others |
-
|
-
|
-
|
|
|
|
Total Operating Expenses |
-
|
-
|
-
| | | |
Operating Income or Loss
|
1,257,000
|
1,293,000
|
1,155,000
| |
|
Income from Continuing Operations |
|
Total Other Income/Expenses Net | 239,000 | 159,000 | 88,000 |
|
Earnings Before Interest And Taxes | 1,438,000 | 1,456,000 | 1,263,000 |
|
Interest Expense | 69,000 | 43,000 | 29,000 |
|
Income Before Tax | 1,369,000 | 1,413,000 | 1,234,000 |
|
Income Tax Expense | 270,000 | 218,000 | 207,000 |
|
Minority Interest |
-
|
-
|
-
|
|
|
|
Net Income From Continuing Ops | 1,106,000 | 1,210,000 | 1,039,000 | |
|
Non-recurring Events |
|
Discontinued Operations |
-
|
-
|
-
|
|
Extraordinary Items |
-
|
-
|
-
|
|
Effect Of Accounting Changes |
-
|
-
|
-
|
|
Other Items |
-
|
-
|
-
| | | |
Net Income
|
1,099,000
|
1,196,000
|
1,027,000
| | Preferred Stock And Other Adjustments |
-
|
-
|
-
| | |
Net Income Applicable To Common Shares
|
1,099,000
|
1,196,000
|
1,027,000
|
|